Amidst the COVID-19 public health crisis, many companies have worked tirelessly to perfect testing technology. Assure Tech, a Chinese company based in Hangzhao, has prevailed with an antibody test with emergency use authorization. This is the first time that the FDA has granted EUA to a point-of-care antibody test for COVID-19. With on-site results statistically similar to or better than laboratory processed results, Assure Tech’s antibody test will provide immediate disclosure of IgG and IgM antibody presence to help slow the spread of COVID-19.
Read more here.
More on: News Regulatory